Clinical trials: Screen Use
Hepatitis C Virus Infection
Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia
Hepatitis C virus infection is a major cause of chronic hepatitis, cirrhosis, and liver cancer. The risk of developing cirrhosis for people with chronic infection with the virus ranges from 15% to 30% over 20 years.
- Trial name
- HCV-PIWD (NCT06463912)
- Testing
- Does not apply
- Where
- Colombia
- Volunteers
- 205 people, healthy volunteers welcome
- Sponsor
- Asociación Colombiana de Hepatología
Health Knowledge, Attitudes, Practice, Alcohol Drinking
An Electronic Brief Alcohol Intervention for Women Attending a Breast Screening Service (Health4Her)
Alcohol is a major modifiable risk factor for female breast cancer; yet, awareness of this risk remains surprisingly low and is not systematically addressed in healthcare settings.
- Trial name
- NCT06019442
- Testing
- Brief alcohol intervention (Health4Her-Automated), Lifestyle health promotion
- Where
- Australia
- Volunteers
- 143 people, healthy volunteers welcome
- Sponsor
- Turning Point
Oral Health, Old Age; Dementia
Evaluation of the Use of a Novel Oral Health Screening Instrument by Caregivers in Nursing Homes
BACKGROUND: Oral health of nursing home residents is often poor. Oral health is related to general health, quality of life and well-being.
- Conditions
- Oral Health, Old Age; Dementia, Long-Term Care, Nursing Homes
- Trial name
- OHS-interRAI (NCT06536322)
- Testing
- OHS-interRAI
- Where
- Belgium
- Volunteers
- 462 people, healthy volunteers welcome
- Sponsor
- KU Leuven
Cancer
Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos.
- Trial name
- CRUZA (NCT01740219)
- Testing
- Capacity Enhancement, Standard Dissemination
- Where
- 3 sites in United States
- Volunteers
- 348 people, healthy volunteers welcome
- Sponsor
- Dana-Farber Cancer Institute
Substance Use Disorders (SUD)
Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT
Objectives: This study evaluates the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia.
- Trial name
- eScreeniPsy (NCT01885026)
- Testing
- eScreen, Assessment only of alcohol and drug use., Internet-based treatment for depression or anxiety
- Where
- Sweden
- Volunteers
- 93 people
- Sponsor
- Karolinska Institutet
Cystic Fibrosis Related Diabetes, Cystic Fibrosis
The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes
The aim of this study is to establish if the self-administered electronic Oral Glucose Tolerance Test kit can increase the annual uptake of screening for CFRD in children who are between 10 and 17 years of age with CF.
- Trial name
- HomeOGTT (NCT02703155)
- Testing
- Home Oral Glucose Tolerance Test kit
- Where
- United Kingdom
- Volunteers
- 30 people
- Sponsor
- Great Ormond Street Hospital for Children NHS Foundation Trust
Healthcare Utilization
THRIVE+ Pharmacy Liaison-Patient Navigation Intervention
This is a pragmatic comparative effectiveness trial (n=364) to compare two screening and referral program models to address health-related social needs (HRSN) among the intermediate risk population of Boston Accountable Care…
- Trial name
- THRIVE+ (NCT03919084)
- Testing
- THRIVE screening and referral, Pharmacy Care Program services, Patient Navigation Services
- Where
- United States
- Volunteers
- 364 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Prostate Cancer, PSA
MRI Prostate for Chinese Men Being Screened for Prostate Cancer
Under the prostate cancer screening protocol of the project 'Prevention of Obesity-related Cancers', men with elevated PSA with higher prostate cancer risk (PSA 4-10 ng/mL with high Prostate Health Index (PHI) ≥35, or PSA>10…
- Conditions
- Prostate Cancer, PSA, MRI
- Trial name
- NCT03891732
- Testing
- MRI prostate
- Where
- 2 sites in Hong Kong
- Volunteers
- 690 people, healthy volunteers welcome
- Sponsor
- Chinese University of Hong Kong
Sedentary Lifestyle
Development and Validation of an Automated Measurement of Child Screen Media Use: FLASH
Children's screen media use has been identified as a prominent cause for sedentary time that has been linked to obesity and metabolic syndrome, as well as other unwanted physiologic, psychosocial, and academic outcomes in…
- Trial name
- NCT03382951
- Where
- United States
- Volunteers
- 321 people
- Sponsor
- Baylor College of Medicine
Opioid Use Disorder, HIV
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Opioid use disorder (OUD) confers a higher risk of acquiring and transmitting infectious diseases, which may have long-term health consequences in Veterans.
- Conditions
- Opioid Use Disorder, HIV, Hepatitis C Virus, Gonorrhea
- Trial name
- NCT06766331
- Testing
- Integrated care
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- VA Office of Research and Development
Methamphetamine Use Disorder
Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics
This study is built upon the STAR-OM study (R01 DA050486) to assess if providing psycho-behavioral interventions and medications for people with primary methamphetamine use disorder (MUD) and without opioid use disorder (OUD) at…
- Trial name
- STAR-OM+ (NCT07121296)
- Testing
- Contingency management for substance use, Contingency management for attendance, Group-based Matrix counseling
- Where
- Vietnam
- Volunteers
- 60 people
- Sponsor
- Hanoi Medical University
Harmful; Use, Alcohol, Hazardous; Use, Alcohol
Primary Care Implementation Study to Scale up EIBI and Reduce Alcohol Related Negative Outcomes
The aim of this implementation study is to compare the effect of tailored training and support (T\&S) for general practioners with T\&S and alcohol community actions and the impact it has on early identification of hazardous and…
- Trial name
- PINO (NCT04398576)
- Testing
- Training and support, Community actions
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- KU Leuven
Substance Use Disorders, Mental Illness
Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings
An estimated 40% of patients in mental health treatment settings engage in hazardous alcohol and/or drug use. One model of intervention that has been shown effective in medical settings to reduce alcohol use and/or promote…
- Trial name
- SBIRT in MH (NCT01883791)
- Testing
- SBIRT, Health Education
- Where
- 2 sites in United States
- Volunteers
- 1,080 people
- Sponsor
- University of California, Los Angeles
Colorectal Cancer
Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
The goal of this study is to improve use of colorectal cancer screening among screening eligible African Americans who are served by Federally Qualified Health Centers in Michigan.
- Trial name
- NCT06085560
- Testing
- Usual Care Message, Implementation Intention Intervention: Standard Message, Implementation Intention Intervention: Culturally-Targeted Message
- Where
- United States
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Michigan State University
Colorectal Cancer Screening, Colon Adenomatous Polyp
Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue
A retrospective and prospective study to determine if the use of ambient lighting during screening colonoscopy is well tolerated and if ambient lighting will help physicians maintain adenoma detection rates while decreasing…
- Trial name
- NCT04441242
- Testing
- Ambient lighting, Low lighting
- Where
- United States
- Volunteers
- 1,109 people
- Sponsor
- Wake Forest University Health Sciences
Laparoscopy, Augmented Reality
Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial
Procedure preparation and accurate knowledge of the specific anatomy is an integral part of performing minimally invasive procedures.
- Conditions
- Laparoscopy, Augmented Reality, Orientation, Spatial, Liver
- Trial name
- LARA (NCT05389241)
- Testing
- Method A, Method B
- Where
- Germany
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Universitätsklinikum Köln
Alcohol Use Disorder
Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
The intent of the study is to develop two versions of the 'ability to resist' drinking model designed to screen Alcohol Use Disorder (AUD) medications.
- Trial name
- NCT06489782
- Testing
- Model 1, Model 2
- Where
- United States
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Yale University
Neonatal Respiratory Distress Related Conditions, Meconium
Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Meconium Exposure
Meconium in the amniotic fluid occurs in about one out of seven pregnancies and increases the chance that a newborn may have breathing problems after birth.
- Conditions
- Neonatal Respiratory Distress Related Conditions, Meconium, Perinatal Morbidity, Neonatal Acidosis
- Trial name
- PEARL (NCT07274527)
- Testing
- Intrauterine pressure catheter, Standard obstetric care at discretion of delivery provider
- Where
- United States
- Volunteers
- 320 people
- Sponsor
- Medical College of Wisconsin
Healthy Volunteer
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
This study will evaluate the specificity of the cobas TaqScreen MPX Test for the simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000 individual donor samples in 96-unit pools.
- Trial name
- NCT00520273
- Testing
- cobas s 201 TaqScreen MPX Test
- Where
- 3 sites in United States
- Volunteers
- 100,000 people, healthy volunteers welcome
- Sponsor
- Hoffmann-La Roche
Schizophrenia, Substance Abuse
Screening Protocol for Research Participants
The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.
- Conditions
- Schizophrenia, Substance Abuse, Cocaine Abuse, Tobacco Use Disorder
- Trial name
- ScreenProt (NCT01010620)
- Testing
- Various Screening psychiatric and medical assessments
- Where
- United States
- Volunteers
- 523 people, healthy volunteers welcome
- Sponsor
- University of Maryland, Baltimore